Phase I clinical trial of idiotypic DNA vaccine administered as a complex with polyethylenimine to patients with B-cell lymphoma

We report on the design of a phase I, non-randomized, open-label study of idiotypic DNA vaccination in patients with B-cell non-Hodgkin's lymphoma (ISRCTN31090206). The study uses DNA fusion gene vaccination encoding patient-specific single chain variable fragment, or idiotype, linked to an imm...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Hum Vaccin Immunother
Egile Nagusiak: Meleshko, A. N., Petrovskaya, N. A., Savelyeva, N., Vashkevich, K. P., Doronina, S. N., Sachivko, N. V.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Taylor & Francis 2017
Gaiak:
Commentary
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5489279/
https://ncbi.nlm.nih.gov/pubmed/28272989
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2017.1285477
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak